FinVector is an internationally renowned biopharmaceutical company that manufactures viral-based gene therapy products. We believe in delivering to market innovative medicines and therapies, which bring renewed hope, purpose, and a true sense of belonging to individuals battling major illnesses. Our state-of-the-art manufacturing facility is located in the beautiful and thriving science and technology area of Savilahti in Kuopio, Finland. Our vibrant and multinational working community consists of hundreds of professionals representing nearly 50 different nationalities, fostering a diverse and collaborative environment. FinVector is a subsidiary of Ferring Ventures S/A.

Learn more: www.finvector.com
Instagram: @finvectorians
LinkedIn: FinVector Oy